Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$19.3K Sell
188
-112
-37% -$12.6K 0.01% 130
2025
Q4
$37.5K Buy
300
+104
+53% +$13.2K 0.01% 92
2025
Q3
$26.3K Sell
196
-12
-6% -$1.57K 0.01% 106
2025
Q2
$28.3K Buy
208
+20
+11% +$2.64K 0.01% 93
2025
Q1
$24.9K Sell
188
-1
-0.5% -$127 0.01% 88
2024
Q4
$21.4K Hold
189
0.01% 97
2024
Q3
$21.5K Hold
189
0.01% 100
2024
Q2
$19.6K Buy
+189
New +$20K 0.01% 103

Other funds holding ABT

Swan Capital's ABT Position: Q1 2026 in Review

Swan Capital reduced its Abbott (ABT) stake by 37% in Q1 2026, selling an estimated $12.6K and leaving 188 shares worth $19.3K. The position accounts for 0.01% of the portfolio, ranked #130.

Swan Capital first reported a position in ABT in Q2 2024 and has held it in 8 quarters since. The position peaked at $37.5K in Q4 2025. 3,083 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Swan Capital held 188 shares of Abbott worth $19.3K as of Q1 2026.
  • Swan Capital sold 112 Abbott shares in Q1 2026, an estimated $12.6K.
  • Abbott made up 0.01% of Swan Capital's portfolio in Q1 2026, its #130 holding.
  • Swan Capital first reported a position in Abbott in Q2 2024 and has held it in 8 quarters since.
  • Swan Capital's Abbott position peaked at $37.5K in Q4 2025.
  • 3,083 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Swan Capital's 13F filing for Q1 2026, filed 14 May 2026.